Literature DB >> 20308189

Identification and characterization of beta-lactamase inhibitor protein-II (BLIP-II) interactions with beta-lactamases using phage display.

N G Brown1, T Palzkill.   

Abstract

Protein-protein interactions are critical to cellular processes yet the ability to predict and rationally design interactions is limited because of incomplete knowledge of the principles governing these interactions. The beta-lactamase inhibitory protein (BLIP)/beta-lactamase interaction has become a model system to investigate protein-protein interactions and has been the focus of several structural, thermodynamic and binding specificity studies. BLIP-II also inhibits beta-lactamase but has no sequence homology with BLIP. The structure of BLIP-II in complex with TEM-1 beta-lactamase revealed that BLIP-II has a completely different structure than BLIP but it interacts with the same protruding loop-helix region of TEM-1 as does BLIP. The significance of the individual interacting residues in molecular recognition by BLIP-II is currently unknown. Therefore, a phage display vector was developed with the purpose of expressing BLIP-II onto the surface of the M13 filamentous bacteriophage. The BLIP-II displayed phage bound to TEM-1 with picomolar affinity indicating that BLIP-II is properly folded while on the surface of the phage. The phage system, as well as enzyme inhibition assays with purified proteins, revealed that BLIP-II is a more potent inhibitor than BLIP for several class A beta-lactamases with K(i) values in the low picomolar range.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20308189      PMCID: PMC2865362          DOI: 10.1093/protein/gzq017

Source DB:  PubMed          Journal:  Protein Eng Des Sel        ISSN: 1741-0126            Impact factor:   1.650


  107 in total

Review 1.  Beta propellers: structural rigidity and functional diversity.

Authors:  V Fülöp; D T Jones
Journal:  Curr Opin Struct Biol       Date:  1999-12       Impact factor: 6.809

Review 2.  Combinatorial alanine-scanning.

Authors:  K L Morrison; G A Weiss
Journal:  Curr Opin Chem Biol       Date:  2001-06       Impact factor: 8.822

3.  Biochemical characterization of beta-lactamases Bla1 and Bla2 from Bacillus anthracis.

Authors:  Isabel C Materon; Anne Marie Queenan; Theresa M Koehler; Karen Bush; Timothy Palzkill
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

4.  Structural and computational characterization of the SHV-1 beta-lactamase-beta-lactamase inhibitor protein interface.

Authors:  Kimberly A Reynolds; Jodi M Thomson; Kevin D Corbett; Christopher R Bethel; James M Berger; Jack F Kirsch; Robert A Bonomo; Tracy M Handel
Journal:  J Biol Chem       Date:  2006-06-29       Impact factor: 5.157

5.  In search of dark horses: affinity maturation of phage-displayed ligands.

Authors:  G P Smith; J Yu
Journal:  Mol Divers       Date:  1996-10       Impact factor: 2.943

6.  A structural basis for mutational inactivation of the tumour suppressor Smad4.

Authors:  Y Shi; A Hata; R S Lo; J Massagué; N P Pavletich
Journal:  Nature       Date:  1997-07-03       Impact factor: 49.962

7.  Identification of a progenitor of the CTX-M-9 group of extended-spectrum beta-lactamases from Kluyvera georgiana isolated in Guyana.

Authors:  Adam B Olson; M Silverman; David A Boyd; Allison McGeer; Barbara M Willey; V Pong-Porter; N Daneman; Michael R Mulvey
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

8.  Beta-lactamase genes of the penicillin-susceptible Bacillus anthracis Sterne strain.

Authors:  Yahua Chen; Janice Succi; Fred C Tenover; Theresa M Koehler
Journal:  J Bacteriol       Date:  2003-02       Impact factor: 3.490

9.  Cloning and sequence analysis of the gene for a carbapenem-hydrolyzing class A beta-lactamase, Sme-1, from Serratia marcescens S6.

Authors:  T Naas; L Vandel; W Sougakoff; D M Livermore; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

10.  Screening and isolation of penicillinase inhibitor, KA-107.

Authors:  Y Iwai; H Ono; H Takeshima; N Yamaguchi; S Omura
Journal:  Antimicrob Agents Chemother       Date:  1973-09       Impact factor: 5.191

View more
  11 in total

1.  Analysis of the binding forces driving the tight interactions between beta-lactamase inhibitory protein-II (BLIP-II) and class A beta-lactamases.

Authors:  Nicholas G Brown; Dar-Chone Chow; Banumathi Sankaran; Peter Zwart; B V Venkataram Prasad; Timothy Palzkill
Journal:  J Biol Chem       Date:  2011-07-20       Impact factor: 5.157

2.  Use of periplasmic target protein capture for phage display engineering of tight-binding protein-protein interactions.

Authors:  Bartlomiej G Fryszczyn; Nicholas G Brown; Wanzhi Huang; Miriam A Balderas; Timothy Palzkill
Journal:  Protein Eng Des Sel       Date:  2011-09-06       Impact factor: 1.650

3.  BLIP-II Employs Differential Hotspot Residues To Bind Structurally Similar Staphylococcus aureus PBP2a and Class A β-Lactamases.

Authors:  Carolyn J Adamski; Timothy Palzkill
Journal:  Biochemistry       Date:  2017-02-16       Impact factor: 3.162

4.  BLIP-II is a highly potent inhibitor of Klebsiella pneumoniae carbapenemase (KPC-2).

Authors:  Nicholas G Brown; Dar-Chone Chow; Timothy Palzkill
Journal:  Antimicrob Agents Chemother       Date:  2013-04-15       Impact factor: 5.191

5.  Identification of the β-lactamase inhibitor protein-II (BLIP-II) interface residues essential for binding affinity and specificity for class A β-lactamases.

Authors:  Nicholas G Brown; Dar-Chone Chow; Kevin E Ruprecht; Timothy Palzkill
Journal:  J Biol Chem       Date:  2013-04-27       Impact factor: 5.157

6.  Role of β-lactamase residues in a common interface for binding the structurally unrelated inhibitory proteins BLIP and BLIP-II.

Authors:  Bartlomiej G Fryszczyn; Carolyn J Adamski; Nicholas G Brown; Kacie Rice; Wanzhi Huang; Timothy Palzkill
Journal:  Protein Sci       Date:  2014-07-01       Impact factor: 6.725

7.  Deep Sequencing of a Systematic Peptide Library Reveals Conformationally-Constrained Protein Interface Peptides that Disrupt a Protein-Protein Interaction.

Authors:  David M Boragine; Wanzhi Huang; Lynn H Su; Timothy Palzkill
Journal:  Chembiochem       Date:  2021-12-07       Impact factor: 3.164

8.  Characterization of the global stabilizing substitution A77V and its role in the evolution of CTX-M β-lactamases.

Authors:  Meha P Patel; Bartlomiej G Fryszczyn; Timothy Palzkill
Journal:  Antimicrob Agents Chemother       Date:  2015-08-17       Impact factor: 5.191

9.  Systematic substitutions at BLIP position 50 result in changes in binding specificity for class A β-lactamases.

Authors:  Carolyn J Adamski; Timothy Palzkill
Journal:  BMC Biochem       Date:  2017-03-06       Impact factor: 4.059

Review 10.  Tackling the Antibiotic Resistance Caused by Class A β-Lactamases through the Use of β-Lactamase Inhibitory Protein.

Authors:  Warawan Eiamphungporn; Nalini Schaduangrat; Aijaz Ahmad Malik; Chanin Nantasenamat
Journal:  Int J Mol Sci       Date:  2018-07-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.